Theravance Biopharma, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Prepaid Expense and Other Assets of $3.62 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2015-11-12
- Theravance Biopharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2015-09-30 was -$689.00K, a 131.13% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2015-06-30 was $3.64M.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2015-03-31 was $674.00K, a 62.78% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2014-12-31 was -$378.00K.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2014 was $2.88M.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2013 was -$19.00K, a 104.90% decline from fiscal 2012.
- Theravance Biopharma, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2012 was $388.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2015-09-30 | -$689.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $2.95M derived: sum of 2 quarters · filed 2015-11-12 | $3.62M 10-Q · filed 2015-11-12 | $3.24M derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | $3.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $4.31M 10-Q · filed 2015-08-13 | $3.93M derived: sum of 3 quarters · filed 2015-08-13 | $6.14M derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-03-31 | $674.00K 10-Q · filed 2015-05-13 | $296.00K derived: sum of 2 quarters · filed 2015-05-13 | $2.51M derived: sum of 3 quarters · filed 2015-11-12 | $1.74M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-12-31 | -$378.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.83M derived: sum of 2 quarters · filed 2015-11-12 | $1.07M derived: sum of 3 quarters · filed 2015-11-12 | $2.88M 10-K · filed 2015-03-13 |
| 2014-09-30 | $2.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.45M derived: sum of 2 quarters · filed 2015-11-12 | $3.26M 10-Q · filed 2015-11-12 | $2.91M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | -$768.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $1.04M 10-Q · filed 2015-08-13 | $698.00K derived: sum of 3 quarters · filed 2015-08-13 | $1.06M derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $1.81M 10-Q · filed 2015-05-13 | $1.47M derived: sum of 2 quarters · filed 2015-05-13 | $1.83M derived: sum of 3 quarters · filed 2015-05-13 | $537.00K derived: sum of 4 quarters · filed 2015-05-13 |
| 2013-12-31 | -$345.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $16.00K derived: sum of 2 quarters · filed 2015-03-13 | -$1.27M derived: sum of 3 quarters · filed 2015-03-13 | -$19.00K 10-K · filed 2015-03-13 |
| 2013-09-30 | $361.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$929.00K derived: sum of 2 quarters · filed 2014-11-12 | $326.00K 10-Q · filed 2014-11-12 | |
| 2013-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$35.00K 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $1.25M 10-Q · filed 2014-06-24 | |||
| 2012-12-31 | $388.00K 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |